{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:28:49Z","timestamp":1787588929489,"version":"build-2736575974"},"reference-count":107,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.jns.2005.04.017","type":"journal-article","created":{"date-parts":[[2005,6,29]],"date-time":"2005-06-29T08:59:57Z","timestamp":1120035597000},"page":"1-9","source":"Crossref","is-referenced-by-count":86,"title":["Expanding use of botulinum toxin"],"prefix":"10.1016","volume":"235","author":[{"given":"Roongroj","family":"Bhidayasiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jns.2005.04.017_bib1","first-page":"155","article-title":"The origin, structure, and pharmacological activity of botulinum toxin","volume":"33","author":"Simpson","year":"1981","journal-title":"Pharmacol Rev"},{"issue":"Suppl 8","key":"10.1016\/j.jns.2005.04.017_bib2","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1002\/mds.20071","article-title":"New therapeutic indications for botulinum toxins","volume":"19","author":"Cordivari","year":"2004","journal-title":"Mov Disord"},{"issue":"5 Suppl","key":"10.1016\/j.jns.2005.04.017_bib3","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/01.PRS.0000082188.55598.34","article-title":"Botulinum toxin: expanding role in medicine","volume":"112","author":"Rohrich","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jns.2005.04.017_bib4","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1002\/(SICI)1097-4598(1997)6+<129::AID-MUS9>3.0.CO;2-B","article-title":"Botulinum toxin: historical perspective and potential new indications","volume":"6","author":"Jankovic","year":"1997","journal-title":"Muscle Nerve Suppl"},{"issue":"3","key":"10.1016\/j.jns.2005.04.017_bib5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1524-4725.2004.30118.x","article-title":"The therapeutic potential of botulinum toxin","volume":"30","author":"Klein","year":"2004","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.jns.2005.04.017_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0041-0101(00)00163-X","article-title":"Tetanus and botulinum neurotoxins: turning bad guys into good by research","volume":"39","author":"Rossetto","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.jns.2005.04.017_bib7","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1002\/(SICI)1097-4598(1997)6+<146::AID-MUS10>3.0.CO;2-4","article-title":"Botulinum toxin: chemistry, pharmacology, toxicity, and immunology","volume":"6","author":"Brin","year":"1997","journal-title":"Muscle Nerve Suppl"},{"issue":"Suppl 8","key":"10.1016\/j.jns.2005.04.017_bib8","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/mds.20010","article-title":"Different types of botulinum toxin in humans","volume":"19","author":"Eleopra","year":"2004","journal-title":"Mov Disord"},{"issue":"Suppl 8","key":"10.1016\/j.jns.2005.04.017_bib9","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1002\/mds.20066","article-title":"Clinical comparability of marketed formulations of botulinum toxin","volume":"19","author":"Sampaio","year":"2004","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.jns.2005.04.017_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(97)13448-6","article-title":"Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human","volume":"224","author":"Eleopra","year":"1997","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.jns.2005.04.017_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mds.870110211","article-title":"Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients","volume":"11","author":"Greene","year":"1996","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.jns.2005.04.017_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.64.1.6","article-title":"A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia","volume":"64","author":"Odergren","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2005.04.017_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000083259","article-title":"Botulinum toxin: mechanisms of action","volume":"53","author":"Dressler","year":"2005","journal-title":"Eur Neurol"},{"issue":"10","key":"10.1016\/j.jns.2005.04.017_bib14","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1517\/14656566.2.10.1649","article-title":"Review of botulinum toxin type A and its clinical applications in migraine headache","volume":"2","author":"Silberstein","year":"2001","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.jns.2005.04.017_bib15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0306-4522(87)90094-7","article-title":"Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous systems","volume":"23","author":"Black","year":"1987","journal-title":"Neuroscience"},{"issue":"Suppl 8","key":"10.1016\/j.jns.2005.04.017_bib16","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1002\/mds.20067","article-title":"Botulinum toxin treatment of secretory disorders","volume":"19","author":"Naumann","year":"2004","journal-title":"Mov Disord"},{"issue":"Suppl 8","key":"10.1016\/j.jns.2005.04.017_bib17","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1002\/mds.20068","article-title":"Botulinum toxin in neuro-urological disorders","volume":"19","author":"Jost","year":"2004","journal-title":"Mov Disord"},{"issue":"Suppl 8","key":"10.1016\/j.jns.2005.04.017_bib18","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1002\/mds.20070","article-title":"Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincters spasms","volume":"19","author":"Brisinda","year":"2004","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.jns.2005.04.017_bib19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1468-1331.2001.00328.x","article-title":"Treatment of relative sialorrhoea with botulinum toxin type A: description and rationale for an injection procedure with case report","volume":"8","author":"Glickman","year":"2001","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.jns.2005.04.017_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.10420","article-title":"Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism","volume":"18","author":"Mancini","year":"2003","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.jns.2005.04.017_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1053\/joms.2003.50086","article-title":"Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies","volume":"61","author":"Ellies","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"6","key":"10.1016\/j.jns.2005.04.017_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-2002-37084","article-title":"Successful management of drooling with botulinum toxin A in neurologically disabled children","volume":"33","author":"Ellies","year":"2002","journal-title":"Neuropediatrics"},{"issue":"1","key":"10.1016\/j.jns.2005.04.017_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00005537-200201000-00014","article-title":"Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy","volume":"112","author":"Suskind","year":"2002","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.jns.2005.04.017_bib24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.54.1.244","article-title":"Botulinum toxin A as treatment for drooling saliva in PD","volume":"54","author":"Pal","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2005.04.017_bib25","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/jnnp.70.4.538","article-title":"Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders","volume":"70","author":"Porta","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2005.04.017_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/jnnp.70.3.417","article-title":"Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach","volume":"70","author":"Winterholler","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.jns.2005.04.017_bib27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jnnp.67.5.697","article-title":"Botulinum toxin is a useful treatment in excessive drooling in saliva","volume":"67","author":"Bhatia","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2005.04.017_bib28","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1212\/WNL.55.4.606-a","article-title":"Botulinum toxin A as treatment for drooling saliva in PD","volume":"55","author":"O'Sullivan","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2005.04.017_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1353-8020(00)00073-0","article-title":"Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin","volume":"7","author":"Friedman","year":"2001","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"10.1016\/j.jns.2005.04.017_bib30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s004310100784","article-title":"Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series","volume":"160","author":"Jongerius","year":"2001","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.jns.2005.04.017_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jnnp.69.1.121","article-title":"Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis","volume":"69","author":"Giess","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2005.04.017_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0887-8994(02)00381-8","article-title":"Botulinum toxin A as a treatment for excessive drooling in children","volume":"27","author":"Bothwell","year":"2002","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.jns.2005.04.017_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clineuro.2003.10.012","article-title":"Ultrasound-guided versus \u2018blind\u2019 intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease","volume":"106","author":"Dogu","year":"2004","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"10.1016\/j.jns.2005.04.017_bib34","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1542\/peds.2003-1104-L","article-title":"Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial","volume":"114","author":"Jongerius","year":"2004","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.jns.2005.04.017_bib35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.61.9.1279","article-title":"A randomized trial of botulinum toxin A for treatment of drooling","volume":"61","author":"Lipp","year":"2003","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jns.2005.04.017_bib36","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/mds.10484","article-title":"Botulinum toxin B reduces sialorrhea in parkinsonism","volume":"18","author":"Racette","year":"2003","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.jns.2005.04.017_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/01.WNL.0000101713.81253.4C","article-title":"A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease","volume":"62","author":"Ondo","year":"2004","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jns.2005.04.017_bib38","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.53.7.1439","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia","volume":"53","author":"Brashear","year":"1999","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jns.2005.04.017_bib39","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1212\/WNL.53.7.1431","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia","volume":"53","author":"Brin","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2005.04.017_bib40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000067023","article-title":"Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis","volume":"49","author":"Dressler","year":"2003","journal-title":"Eur Neurol"},{"issue":"1\u20132","key":"10.1016\/j.jns.2005.04.017_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-510X(01)00565-2","article-title":"Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis","volume":"190","author":"Tan","year":"2001","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.jns.2005.04.017_bib42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1055\/s-2004-817724","article-title":"Disorders of sweating","volume":"23","author":"Cheshire","year":"2003","journal-title":"Semin Neurol"},{"key":"10.1016\/j.jns.2005.04.017_bib43","series-title":"Handbook of autonomic nervous system dysfunction","article-title":"Hyperhidrosis of the palms and soles","author":"Mosek","year":"1995"},{"issue":"5","key":"10.1016\/j.jns.2005.04.017_bib44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0090-3019(99)00111-1","article-title":"Transthoracic endoscopic sympathectomy in the treatment of palmar hyperhidrosis\u2013with emphasis on perioperative management (1,360 case analyses)","volume":"52","author":"Lin","year":"1999","journal-title":"Surg Neurol"},{"issue":"12","key":"10.1016\/j.jns.2005.04.017_bib45","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1790::AID-MUS26>3.0.CO;2-I","article-title":"Selective degeneration of sudomotor fibers in Ross syndrome and successful treatment of compensatory hyperhidrosis with botulinum toxin","volume":"21","author":"Bergmann","year":"1998","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.jns.2005.04.017_bib46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00006534-200207000-00039","article-title":"Hyperhidrosis: a review of current management","volume":"110","author":"Atkins","year":"2002","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.jns.2005.04.017_bib47","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0190-9622(99)70258-6","article-title":"Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis","volume":"41","author":"Heckmann","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jns.2005.04.017_bib48","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2133.1999.02769.x","article-title":"A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis","volume":"140","author":"Schnider","year":"1999","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jns.2005.04.017_bib49","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ana.410420619","article-title":"Treatment of gustatory sweating with botulinum toxin","volume":"42","author":"Naumann","year":"1997","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.jns.2005.04.017_bib50","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaad.2004.07.030","article-title":"Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin","volume":"51","author":"Swartling","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"7313","key":"10.1016\/j.jns.2005.04.017_bib51","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/bmj.323.7313.596","article-title":"Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial","volume":"323","author":"Naumann","year":"2001","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jns.2005.04.017_bib52","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1046\/j.1365-2133.2002.05059.x","article-title":"Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial","volume":"147","author":"Naumann","year":"2002","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jns.2005.04.017_bib53","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2133.1997.tb02139.x","article-title":"Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms","volume":"136","author":"Schnider","year":"1997","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jns.2005.04.017_bib54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archderm.134.3.301","article-title":"Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin","volume":"134","author":"Naumann","year":"1998","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jns.2005.04.017_bib55","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1046\/j.1365-2133.1998.2576k.x","article-title":"Botulinum toxin for focal hyperhidrosis: technical considerations and improvements in application","volume":"139","author":"Naumann","year":"1998","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jns.2005.04.017_bib56","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0003-9993(98)90020-X","article-title":"Axillary hyperhidrosis: treatment with botulinum toxin A","volume":"79","author":"Odderson","year":"1998","journal-title":"Arch Phys Med Rehabil"},{"issue":"2 Pt 1","key":"10.1016\/j.jns.2005.04.017_bib57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0190-9622(98)70242-7","article-title":"Botulinum toxin therapy for palmar hyperhidrosis","volume":"38","author":"Shelley","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jns.2005.04.017_bib58","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/archneur.56.8.914","article-title":"Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system","volume":"56","author":"Naumann","year":"1999","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.jns.2005.04.017_bib59","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1076-0512(98)00077-6","article-title":"Botulinum A neurotoxin for axillary hyperhidrosis. No sweat Botox","volume":"24","author":"Glogau","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jns.2005.04.017_bib60","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1111\/j.1468-1331.1999.tb00028.x","article-title":"Treatment of focal hyperhidrosis with botulinum toxin type A. Brief overview of methodology and 2 years' experience","volume":"6","author":"Naver","year":"1999","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.jns.2005.04.017_bib61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1468-1331.2000.00014.x","article-title":"Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up","volume":"7","author":"Naver","year":"2000","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.jns.2005.04.017_bib62","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM200102153440704","article-title":"Botulinum toxin A for axillary hyperhidrosis (excessive sweating)","volume":"344","author":"Heckmann","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jns.2005.04.017_bib63","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0190-9622(00)90298-6","article-title":"Botulinum toxin type A therapy for palmar and digital hyperhidrosis","volume":"42","author":"Solomon","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jns.2005.04.017_bib64","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archderm.136.4.487","article-title":"Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase","volume":"136","author":"Karamfilov","year":"2000","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jns.2005.04.017_bib65","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1365-2133.2000.03839.x","article-title":"Effective treatment of frontal hyperhidrosis with botulinum toxin A","volume":"143","author":"Kinkelin","year":"2000","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jns.2005.04.017_bib66","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archotol.125.3.283","article-title":"Recurrent gustatory sweating (Frey syndrome) after intracutaneous injection of botulinum toxin type A: incidence, management, and outcome","volume":"125","author":"Laccourreye","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.jns.2005.04.017_bib67","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archderm.139.2.226","article-title":"Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis","volume":"139","author":"Baumann","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jns.2005.04.017_bib68","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clindermatol.2003.11.001","article-title":"Botulinum toxin-B and the management of hyperhidrosis","volume":"22","author":"Baumann","year":"2004","journal-title":"Clin Dermatol"},{"issue":"12","key":"10.1016\/j.jns.2005.04.017_bib69","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00415-002-0929-4","article-title":"Botulinum toxin type B for treatment of axillar hyperhidrosis","volume":"249","author":"Dressler","year":"2002","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.jns.2005.04.017_bib70","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1067\/mhn.2000.110960","article-title":"Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study","volume":"123","author":"Binder","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.jns.2005.04.017_bib71","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/WNL.40.2.277","article-title":"Botulinum toxin injections for cervical dystonia","volume":"40","author":"Jankovic","year":"1990","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2005.04.017_bib72","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1526-4610.2000.00066.x","article-title":"Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group","volume":"40","author":"Silberstein","year":"2000","journal-title":"Headache"},{"issue":"10","key":"10.1016\/j.jns.2005.04.017_bib73","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1526-4610.2002.02234.x","article-title":"Relief of tension-type headache symptoms in subjects with temporomandibular disorders treated with botulinum toxin-A","volume":"42","author":"Freund","year":"2002","journal-title":"Headache"},{"issue":"3 Suppl 1","key":"10.1016\/j.jns.2005.04.017_bib74","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1053\/apmr.2003.50121","article-title":"Botulinum toxin type A therapy in chronic pain disorders","volume":"84","author":"Lang","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"issue":"Suppl 1","key":"10.1016\/j.jns.2005.04.017_bib75","doi-asserted-by":"crossref","first-page":"I36","DOI":"10.1007\/s00415-004-1109-5","article-title":"Consensus statement: botulinum toxin in myofascial pain","volume":"251","author":"Reilich","year":"2004","journal-title":"J Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.jns.2005.04.017_bib76","first-page":"I19","article-title":"Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature","volume":"251","author":"Sycha","year":"2004","journal-title":"J Neurol"},{"issue":"10","key":"10.1016\/j.jns.2005.04.017_bib77","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/WNL.56.10.1290","article-title":"Botulinum toxin A and chronic low back pain: a randomized, double-blind study","volume":"56","author":"Foster","year":"2001","journal-title":"Neurology"},{"issue":"8501","key":"10.1016\/j.jns.2005.04.017_bib78","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"2","author":"Tsui","year":"1986","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jns.2005.04.017_bib79","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1212\/WNL.40.8.1213","article-title":"Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis","volume":"40","author":"Greene","year":"1990","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2005.04.017_bib80","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/mds.870060210","article-title":"Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients","volume":"6","author":"Lorentz","year":"1991","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.jns.2005.04.017_bib81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/PL00007848","article-title":"A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia","volume":"249","author":"Naumann","year":"2002","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.jns.2005.04.017_bib82","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.870020402","article-title":"Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm","volume":"2","author":"Brin","year":"1987","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"10.1016\/j.jns.2005.04.017_bib83","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1007\/s00415-004-1102-z","article-title":"Neurobiological basis for the use of botulinum toxin in pain therapy","volume":"251","author":"Mense","year":"2004","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.jns.2005.04.017_bib84","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8","article-title":"Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection","volume":"19","author":"Rosales","year":"1996","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.jns.2005.04.017_bib85","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1526-4610.2004.04154.x","article-title":"Botulinum toxin type A for the treatment of headache: pro","volume":"44","author":"Blumenfeld","year":"2004","journal-title":"Headache"},{"issue":"8","key":"10.1016\/j.jns.2005.04.017_bib86","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1526-4610.2004.04155.x","article-title":"Botulinum toxin type A for the treatment of headache: con","volume":"44","author":"Welch","year":"2004","journal-title":"Headache"},{"issue":"Suppl 4","key":"10.1016\/j.jns.2005.04.017_bib87","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1111\/j.1468-1331.1999.tb00044.x","article-title":"Prophylactive treatment of chronic tension-type headache using botulinum toxin type A","volume":"6","author":"Smuts","year":"1999","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2005.04.017_bib88","first-page":"455","article-title":"Treatment of chronic tension-type headache with botulinum toxin","volume":"19","author":"Gobel","year":"1999","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.jns.2005.04.017_bib89","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1526-4610.2000.00044.x","article-title":"Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study","volume":"40","author":"Rollnik","year":"2000","journal-title":"Headache"},{"key":"10.1016\/j.jns.2005.04.017_bib90","first-page":"486","article-title":"Treatment of frontal tension headaches with botulinum toxin","volume":"21","author":"Burch","year":"2001","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.jns.2005.04.017_bib91","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1526-4610.2001.041007658.x","article-title":"Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial","volume":"41","author":"Schmitt","year":"2001","journal-title":"Headache"},{"key":"10.1016\/j.jns.2005.04.017_bib92","first-page":"634","article-title":"The therapeutic effect of botulinum toxin on tension-type headache: a multicenter, randomized, double-blind, placebo-controlled study","volume":"23","author":"Schulte-Mattler","year":"2003","journal-title":"Cephalalgia"},{"issue":"1\u20132","key":"10.1016\/j.jns.2005.04.017_bib93","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pain.2004.01.016","article-title":"Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study","volume":"109","author":"Schulte-Mattler","year":"2004","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jns.2005.04.017_bib94","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1468-2982.2004.00641.x","article-title":"Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study","volume":"24","author":"Ondo","year":"2004","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.jns.2005.04.017_bib95","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1468-2982.2004.00738.x","article-title":"Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial","volume":"24","author":"Padberg","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jns.2005.04.017_bib96","first-page":"421","article-title":"Botox for migraine: double-blind, placebo-controlled, region-specific evaluation","volume":"20","author":"Brin","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jns.2005.04.017_bib97","first-page":"702","article-title":"Botulinum toxin A in the prophylactic treatment of migraine-a randomised, double-blind, placebo-controlled study","volume":"23","author":"Schwaag","year":"2003","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.jns.2005.04.017_bib98","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s11916-002-0054-1","article-title":"The use of botulinum toxin in the treatment of headaches","volume":"6","author":"Mauskop","year":"2002","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.jns.2005.04.017_bib99","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10194-003-0049-2","article-title":"Botulinum toxin type A in the prophylactic treatment of migraine headache: a preliminary study","volume":"4","author":"Barrientos","year":"2003","journal-title":"J Headaches Pain"},{"issue":"10","key":"10.1016\/j.jns.2005.04.017_bib100","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1526-4610.2003.03210.x","article-title":"Single-site botulinum toxin type a injection for elimination of migraine trigger points","volume":"43","author":"Behmand","year":"2003","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.jns.2005.04.017_bib101","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1524-4725.2003.29183.x","article-title":"Botulinum toxin: application into acupuncture points for migraine","volume":"29","author":"Tamura","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jns.2005.04.017_bib102","first-page":"739","article-title":"Duration of migraine illness is a predictor for response to botulinum toxin type A","volume":"23","author":"Eross","year":"2003","journal-title":"Cephalalgia"},{"issue":"10","key":"10.1016\/j.jns.2005.04.017_bib103","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1468-2982.2004.00754.x","article-title":"Botulinum toxin A in the prophylactic treatment of migraine\u2013a randomized, double-blind, placebo-controlled study","volume":"24","author":"Evers","year":"2004","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.jns.2005.04.017_bib104","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1526-4610.2003.03163.x","article-title":"Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders","volume":"43","author":"Blumenfeld","year":"2003","journal-title":"Headache"},{"key":"10.1016\/j.jns.2005.04.017_bib105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.12968\/hosp.2003.64.8.2258","article-title":"Movement, visceral and autonomic disorders: use of botulinum toxin","volume":"64","author":"Moore","year":"2003","journal-title":"Hosp Med"},{"issue":"6","key":"10.1016\/j.jns.2005.04.017_bib106","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/archderm.139.6.731","article-title":"Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study","volume":"139","author":"Naumann","year":"2003","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jns.2005.04.017_bib107","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1067\/mjd.2002.118341","article-title":"High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval","volume":"46","author":"Wollina","year":"2002","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X05001607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X05001607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T18:56:10Z","timestamp":1548356170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X05001607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":107,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0022510X05001607"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2005.04.017","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}